Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.650
-0.041 (-5.92%)
At close: Apr 28, 2026, 4:00 PM EDT
0.660
+0.010 (1.52%)
After-hours: Apr 28, 2026, 7:58 PM EDT
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $14.55 million as of April 28, 2026. Its market cap has increased by 79.59% in one year.
Market Cap
14.55M
Enterprise Value
8.66M
1-Year Change
79.59%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $14.55M, a decrease of -52.62%. That is a compound annual growth rate of -8.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 14.50M | -9.94% |
| Dec 31, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 17.55M |
| Genenta Science | 17.40M |
| Pasithea Therapeutics | 17.21M |
| Theriva Biologics | 16.23M |
| Psyence Biomedical | 16.17M |
| IN8bio | 15.36M |
| SeaStar Medical Holding | 15.22M |
| Vyome Holdings | 15.09M |